 |
Clinical Testing Services
BioScience Laboratories has twenty years of experience performing clinical studies testing a wide variety of products. Receive a copy of our latest white paper: How May the Requirement to Meet the Lower Bound of the 95% Confidence Interval Affect the Sample Size for a Study?
BioScience Laboratories offers high quality results. Our Saff are highly trianed in FDA's Tentative Final Monograph (TFM) and ASTM. We have been in operation for over 20 years, our teams extensive knowledge and experience allows us to offer the best quality results possible.
|
View the Human-Use Antieptic Drugs Draft Guidance Document released by Health Canada.
|
|
Antimicrobial Persistence Evaluations
- Agar Patch
- Cup-Scrub Retrieval Past-Exposure
- Extended-Use Claims
|
 |
|
Consumer Product Evaluations
- Cade and Modified Cade Handwashes
- Non-Water-Aided Hand Sanitizers
- General-Use Antimicrobials Soaps
- Food-Handler Handwashes
|
|
Generic Pharmaceuticals
|
|
Healthcare Evaluations
|
|
Skin Technology
|
|
Virology
|
|
Sequestering Facilities
Sequestering Facilities are available for:
- Proof-of-Concept Studies
- Phase I-Phase III Studies
- Bioavailability Studies
- Bioequivalence Studies
- Pharmacokinetics
- Dosing Studies
|
|
|
|
|
Gallatin Institutional Review Board
To protect the well-being and health of the subject volunteers, BioScience Laboratories, contracts the services of the Gallatin Institutional Review Board (GIRB), which comprises seven members – two physicians, three nurses, one member of the clergy, and a member from the general public. The GIRB operates in accordance with guidelines specified in 21 CFR Parts 50 and 56 and is registered with the OHRP and the FDA. Prior to recruitment of subjects, the GIRB reviews and approves study protocols for safety and ethical propriety. The GIRB also ensures that unexpected and/or untoward physical reaction of any kind experienced by a subject during the course of a clinical study, termed and Adverse Event (AE), is addressed, treated, and resolved appropriately and in a timely way.
|
|
Presentations given by the Clinical Laboratory staff:
Investigation of a Surgical Hand Antiseptic Containing 70% Ethanol and a Ployquaternium Polymer Synergist: Antimicrobial Efficacy Skin Tolerance and End User Acceptance
David R. Macings, Ph.D., Marcia Snyder, BA, Carrie A Kolly, BS, Robert R McCormack, BA, and Barry T Reece, MS,MBA; GOJO Industries, Inc., Akron, OH; BioScience Laboratories, Bozeman, MT; RCTS, Inc., Irving, TX
|
|
Contact our experts with your questions about Clinical Trials.
|
|
|
|
